Cerebral Amyloid Angiopathy Research Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Cerebral Amyloid Angiopathy Research Center

Cerebral Amyloid Angiopathy Research Center

J. Philip Kistler Stroke Research Center
175 Cambridge Street, Suite 300
Boston, Massachusetts, United States
Phone   Web  
Cerebral Amyloid Angiopathy Research Center is a group of Massachusetts General Hospital physician-investigators, scientists, and other research staff. Their research focuses on the development, diagnosis, and treatment of cerebral amyloid angiopathy (CAA). CAA is an important cause of cerebral hemorrhage in the elderly. It is currently one of the few kinds of strokes without effective prevention or treatment strategies. 
 
The research is divided into a clinical program that focuses on the molecular epidemiology of CAA and a laboratory program studying its pathogenesis. Their clinical research program has assembled a cohort of patients with probable CAA-related cerebral hemorrhage.
 

The goal of their studies is to:

• Identify safe and effective treatments for lowering the risk of recurrent hemorrhage and other forms of clinical deterioration in patients with CAA, such as vascular cognitive impairment.

• Predict a patient’s risk for hemorrhage and thereby allow treatments that affect blood clotting to be used more safely and effectively.

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close